← zu den Großinvestoren
Soleus Capital Management, L.P.
institutioneller Anleger · Portfolio $2.90 Mrd. · 97 Positionen · Bericht zum 30.06.2026
Aktienpositionen Bericht für 30.06.2026, eingereicht am 11.08.2026; Veränderung – ggü. 31.03.2026 · 97
| Unternehmen | Aktien | Wert | % des Portfolios | Veränderung im Quartal |
|---|---|---|---|---|
| Krystal Biotech Inc US:KRYS | 939 254 | $349 Mio. | 12.03% | neu |
| Celcuity LLC US:CELC | 1 704 318 | $178 Mio. | 6.14% | neu |
| TG Therapeutics Inc US:TGTX | 2 927 895 | $161 Mio. | 5.54% | neu |
| Insulet Corporation US:PODD | 1 049 000 | $160 Mio. | 5.50% | neu |
| NOVOCURE LTD CUSIP G6674U108 | 9 913 401 | $150 Mio. | 5.18% | neu |
| UNITED THERAPEUTICS Corp US:UTHR | 225 587 | $122 Mio. | 4.21% | neu |
| Inspire Medical Systems Inc US:INSP | 1 931 436 | $86.2 Mio. | 2.97% | neu |
| Rigel Pharmaceuticals Inc US:RIGL | 1 843 504 | $72.1 Mio. | 2.49% | neu |
| ANI Pharmaceuticals Inc US:ANIP | 867 760 | $71.8 Mio. | 2.48% | neu |
| Beta Bionics, Inc. US:BBNX | 4 393 714 | $68.8 Mio. | 2.37% | neu |
| Vericel Corp Ord US:VCEL | 1 459 152 | $64.9 Mio. | 2.24% | neu |
| Praxis Precision Medicines I… US:PRAX | 177 517 | $59.4 Mio. | 2.05% | neu |
| Geron Corporation US:GERN | 42 808 659 | $54.8 Mio. | 1.89% | neu |
| ALKERMES PLC CUSIP G01767105 | 1 029 252 | $53.9 Mio. | 1.86% | neu |
| Erasca Inc US:ERAS | 2 700 000 | $49.5 Mio. | 1.70% | neu |
| NeuroPace Inc US:NPCE | 2 911 122 | $46.3 Mio. | 1.59% | neu |
| Progyny Inc US:PGNY | 1 602 000 | $46.2 Mio. | 1.59% | neu |
| Indivior PLC US:INDV | 1 064 000 | $43.7 Mio. | 1.50% | neu |
| Parabilis Medicines, Inc. US:PBLS | 1 465 070 | $40.1 Mio. | 1.38% | neu |
| EDAP TMS S.A. US:FOCL | 7 309 254 | $37.9 Mio. | 1.30% | neu |
| Globus Medical US:GMED | 468 922 | $37.0 Mio. | 1.28% | neu |
| Arcus Biosciences Inc US:RCUS | 1 168 738 | $36.0 Mio. | 1.24% | neu |
| Syndax Pharmaceuticals Inc US:SNDX | 1 628 039 | $35.6 Mio. | 1.23% | neu |
| Nurix Therapeutics Inc US:NRIX | 1 465 163 | $35.5 Mio. | 1.22% | neu |
| Legend Biotech Corp US:LEGN | 1 205 000 | $34.8 Mio. | 1.20% | neu |
| Jade Biosciences, Inc. US:JBIO | 1 550 690 | $34.5 Mio. | 1.19% | neu |
| UNITEDHEALTH GROUP INC US:UNH | 80 000 | $33.3 Mio. | 1.15% | neu |
| Avalo Therapeutics Inc US:AVTX | 1 654 978 | $30.6 Mio. | 1.05% | neu |
| UROGEN PHARMA LTD CUSIP M96088105 | 829 810 | $30.5 Mio. | 1.05% | neu |
| MBX Biosciences, Inc. US:MBX | 515 279 | $28.4 Mio. | 0.98% | neu |
| Palisade Bio Inc US:PALI | 13 063 687 | $27.3 Mio. | 0.94% | neu |
| PHARVARIS N V CUSIP N69605108 | 730 907 | $25.3 Mio. | 0.87% | neu |
| Organogenesis Holdings Inc US:ORGO | 10 140 951 | $24.6 Mio. | 0.85% | neu |
| Supernus Pharmaceuticals Inc US:SUPN | 520 000 | $24.2 Mio. | 0.83% | neu |
| PROCEPT BioRobotics Corp US:PRCT | 1 003 000 | $22.6 Mio. | 0.78% | neu |
| Tango Therapeutics, Inc. US:TNGX | 709 000 | $22.2 Mio. | 0.76% | neu |
| Inhibikase Therapeutics Inc US:IKT | 10 875 000 | $22.1 Mio. | 0.76% | neu |
| Trevi Therapeutics Inc US:TRVI | 1 179 618 | $22.0 Mio. | 0.76% | neu |
| Biomarin Pharmaceutical Inc US:BMRN | 375 572 | $21.5 Mio. | 0.74% | neu |
| LIVANOVA PLC CUSIP G5509L101 | 254 957 | $21.0 Mio. | 0.72% | neu |
| argenx NV ADR US:ARGX | 19 955 | $18.5 Mio. | 0.64% | neu |
| Nuvectis Pharma Inc US:NVCT | 1 000 000 | $18.4 Mio. | 0.63% | neu |
| Capricor Therapeutics Inc US:CAPR | 761 737 | $18.3 Mio. | 0.63% | neu |
| Edgewise Therapeutics Inc US:EWTX | 450 889 | $18.3 Mio. | 0.63% | neu |
| Prelude Therapeutics Inc US:PRLD | 3 378 378 | $18.0 Mio. | 0.62% | neu |
| Xenon Pharmaceuticals Inc US:XENE | 267 000 | $16.1 Mio. | 0.56% | neu |
| C4 Therapeutics, Inc. US:CCCC | 3 377 981 | $15.8 Mio. | 0.54% | neu |
| KINIKSA PHARMACEUTICALS INTL CUSIP G52694109 | 246 353 | $15.8 Mio. | 0.54% | neu |
| Orthopediatrics Corp US:KIDS | 732 144 | $14.0 Mio. | 0.48% | neu |
| Avalyn Pharma Inc. US:AVLN | 419 000 | $13.8 Mio. | 0.48% | neu |
| Biodesix Inc US:BDSX | 585 958 | $13.2 Mio. | 0.46% | neu |
| Spyre Therapeutics Inc. US:SYRE | 147 000 | $13.1 Mio. | 0.45% | neu |
| Twist Bioscience Corp US:TWST | 104 629 | $10.8 Mio. | 0.37% | neu |
| Vir Biotechnology Inc US:VIR | 1 000 000 | $10.2 Mio. | 0.35% | neu |
| Alnylam Pharmaceuticals Inc US:ALNY | 33 050 | $9.95 Mio. | 0.34% | neu |
| Immunovant, Inc. US:IMVT | 252 000 | $9.71 Mio. | 0.33% | neu |
| Insmed Inc US:INSM | 90 250 | $9.62 Mio. | 0.33% | neu |
| Septerna, Inc. US:SEPN | 275 000 | $9.21 Mio. | 0.32% | neu |
| SOPHIA GENETICS SA CUSIP H82027105 | 1 565 000 | $9.03 Mio. | 0.31% | neu |
| NEKTAR THERAPEUTICS US:NKTR | 128 362 | $8.96 Mio. | 0.31% | neu |
| Mirum Pharmaceuticals Inc US:MIRM | 75 000 | $8.78 Mio. | 0.30% | neu |
| Artivion Inc US:AORT | 388 000 | $8.72 Mio. | 0.30% | neu |
| Tandem Diabetes Care Inc US:TNDM | 575 000 | $8.68 Mio. | 0.30% | neu |
| Enliven Therapeutics Inc. US:ELVN | 165 677 | $8.41 Mio. | 0.29% | neu |
| Sionna Therapeutics, Inc. US:SION | 177 687 | $7.82 Mio. | 0.27% | neu |
| Belite Bio Inc ADR US:BLTE | 50 524 | $7.78 Mio. | 0.27% | neu |
| Cerus Corporation US:CERS | 2 500 000 | $7.30 Mio. | 0.25% | neu |
| Silence Therapeutics PLC US:SLN | 630 000 | $6.92 Mio. | 0.24% | neu |
| Immunic Inc US:IMUX | 450 000 | $6.92 Mio. | 0.24% | neu |
| Invivyd Inc. US:IVVD | 7 708 727 | $6.73 Mio. | 0.23% | neu |
| MERCK & CO INC US:MRK | 50 000 | $6.43 Mio. | 0.22% | neu |
| Relmada Therapeutics Inc US:RLMD | 842 106 | $5.83 Mio. | 0.20% | neu |
| Structure Therapeutics Inc.… US:GPCR | 107 000 | $5.74 Mio. | 0.20% | neu |
| Evolus Inc US:EOLS | 822 428 | $5.71 Mio. | 0.20% | neu |
| Adlai Nortye Group Ltd. US:ANL | 405 523 | $4.66 Mio. | 0.16% | neu |
| Zentalis Pharmaceuticals Llc US:ZNTL | 950 000 | $4.61 Mio. | 0.16% | neu |
| Karyopharm Therapeutics Inc. US:KPTI | 440 000 | $4.30 Mio. | 0.15% | neu |
| Context Therapeutics Inc US:CNTX | 7 063 141 | $3.91 Mio. | 0.13% | neu |
| Pulmonx Corp US:LUNG | 2 788 323 | $3.62 Mio. | 0.12% | neu |
| SAB Biotherapeutics Inc US:SABS | 900 000 | $3.51 Mio. | 0.12% | neu |
| Tectonic Therapeutic, Inc. US:TECX | 101 684 | $3.50 Mio. | 0.12% | neu |
| Axogen Inc US:AXGN | 57 036 | $2.63 Mio. | 0.09% | neu |
| Satellos Bioscience Inc. US:MSLE | 314 359 | $2.44 Mio. | 0.08% | neu |
| ArriVent BioPharma, Inc. US:AVBP | 50 000 | $1.74 Mio. | 0.06% | neu |
| Corcept Therapeutics Incorpo… US:CORT | 19 653 | $1.71 Mio. | 0.06% | neu |
| Solid Biosciences LLC US:SLDB | 150 000 | $1.50 Mio. | 0.05% | neu |
| Veracyte Inc US:VCYT | 25 000 | $1.47 Mio. | 0.05% | neu |
| Cullinan Therapeutics, Inc. US:CGEM | 50 000 | $911 Tsd. | 0.03% | neu |
| InspireMD Inc US:NSPR | 1 045 708 | $732 Tsd. | 0.03% | neu |
| GeneDx Holdings Corp. US:WGS | 10 000 | $687 Tsd. | 0.02% | neu |
| Iovance Biotherapeutics Inc US:IOVA | 150 000 | $624 Tsd. | 0.02% | neu |
| Larimar Therapeutics Inc US:LRMR | 188 102 | $574 Tsd. | 0.02% | neu |
| CG Oncology, Inc. US:CGON | 5 000 | $355 Tsd. | 0.01% | neu |
| Quoin Pharmaceuticals Ltd DR… US:QNRX | 72 730 | $352 Tsd. | 0.01% | neu |
| Equillium Inc US:EQ | 90 000 | $288 Tsd. | 0.01% | neu |
| Natera, Inc. US:NTRA | 1 000 | $271 Tsd. | 0.01% | neu |
| NeoGenomics Inc US:NEO | 10 000 | $146 Tsd. | 0.01% | neu |
In Unternehmen Unserer Datenbank 12
| Unternehmen | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| EDAP TMS S.A. | 19.48% | 7 309 254 | 2026-06-30 |
| Novocure Ltd | 8.51% | 9 913 401 | 2026-06-30 |
| Beta Bionics, Inc. | 8.08% | 4 393 714 | 2026-06-30 |
| Context Therapeutics Inc | 7.69% | 7 063 141 | 2026-06-30 |
| Geron Corporation | 6.66% | 42 808 659 | 2026-06-30 |
| Biodesix Inc | 5.55% | 585 958 | 2026-06-30 |
| ANI Pharmaceuticals Inc | 3.78% | 867 760 | 2026-06-30 |
| Celcuity LLC | 3.48% | 1 704 318 | 2026-06-30 |
| Quoin Pharmaceuticals Ltd DR… | 2.33% | 72 730 | 2026-06-30 |
| TG Therapeutics Inc | 1.91% | 2 927 895 | 2026-06-30 |
| Sophia Genetics SA | 1.87% | 1 565 000 | 2026-06-30 |
| Silence Therapeutics PLC | 1.05% | 630 000 | 2026-06-30 |
Anzeige